Low molecular weight inhibitors of cathepsins B, H and T in human serum, synovial fluid and CSF. - Suppr | 超能文献

Low molecular weight inhibitors of cathepsins B, H and T in human serum, synovial fluid and CSF.

作者信息

Lenney J F, Liao J R, Sugg S L, Gopalakrishnan V, Wong H C, Ouye K H, Chan P W

出版信息

Biochem Biophys Res Commun. 1982 Oct 29;108(4):1581-7. doi: 10.1016/s0006-291x(82)80088-0.

DOI:10.1016/s0006-291x(82)80088-0

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Low molecular weight inhibitors of cathepsins B, H and T in human serum, synovial fluid and CSF.

Biochem Biophys Res Commun. 1982 Oct 29;108(4):1581-7. doi: 10.1016/s0006-291x(82)80088-0.

2

Lysosomal thiol cathepsins and their endogenous inhibitors. Distribution and localization.溶酶体硫醇组织蛋白酶及其内源性抑制剂。分布与定位。

Prog Clin Biol Res. 1985;180:71-9.

3

Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases.不同关节疾病患者血清和滑液中组织蛋白酶B和H的测定。

J Clin Chem Clin Biochem. 1990 Mar;28(3):149-53. doi: 10.1515/cclm.1990.28.3.149.

4

A heat stable low molecular weight inhibitor of lysosomal cysteine proteinases in human serum.人血清中一种热稳定的溶酶体半胱氨酸蛋白酶低分子量抑制剂。

Biochem Biophys Res Commun. 1983 Jan 27;110(2):449-55. doi: 10.1016/0006-291x(83)91170-1.

5

Inhibitory effect of human urinary trypsin inhibitor (urinastatin) on lysosomal thiol proteinases.人尿胰蛋白酶抑制剂（乌司他丁）对溶酶体巯基蛋白酶的抑制作用。

Jpn J Pharmacol. 1986 Dec;42(4):571-4. doi: 10.1254/jjp.42.571.

6

[Variation in activity of kidney and liver cysteine cathepsins].

Biull Eksp Biol Med. 1995 Dec;120(12):586-9.

7

Rat liver thiol proteinases: cathepsin B, cathepsin H and cathepsin L.大鼠肝脏硫醇蛋白酶：组织蛋白酶B、组织蛋白酶H和组织蛋白酶L。

Acta Biol Med Ger. 1981;40(10-11):1419-25.

8

Human kidney cathepsins B and H activate and lower the molecular weight of human inactive renin.人肾组织中的组织蛋白酶B和H可激活人无活性肾素并降低其分子量。

Clin Exp Hypertens A. 1982;4(11-12):2149-58. doi: 10.3109/10641968209062378.

9

A new purification procedure of human kidney cathepsin H, its properties and kinetic data.人肾组织组织蛋白酶H的一种新纯化方法、其性质及动力学数据。

Biol Chem Hoppe Seyler. 1988 May;369 Suppl:175-83.

10

Assay procedures for cathepsin B, H and L activities in rat tissue homogenates.大鼠组织匀浆中组织蛋白酶B、H和L活性的测定方法。

Acta Med Okayama. 1986 Feb;40(1):27-32. doi: 10.18926/AMO/31944.

引用本文的文献

1

Protein and non-protein sulfhydryls and disulfides in gastric mucosa and liver after gastrotoxic chemicals and sucralfate: possible new targets of pharmacologic agents.胃毒性化学物质和硫糖铝作用后胃黏膜及肝脏中的蛋白质和非蛋白质巯基与二硫键：药物可能的新靶点

World J Gastroenterol. 2007 Apr 14;13(14):2053-60. doi: 10.3748/wjg.v13.i14.2053.

2

Inhibition of human liver cathepsin L by alpha 2 cysteine-proteinase inhibitor and the low-Mr cysteine proteinase inhibitor from human serum.α2半胱氨酸蛋白酶抑制剂和人血清中的低分子量半胱氨酸蛋白酶抑制剂对人肝脏组织蛋白酶L的抑制作用

Biochem J. 1984 May 15;220(1):147-55. doi: 10.1042/bj2200147.

3

Immunolocalization of human cystatins in neutrophils and lymphocytes.

Histochemistry. 1984;80(4):373-7. doi: 10.1007/BF00495420.